This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2009 Aug;56(2):257-8; discussion 258-9.

doi: 10.1016/j.eururo.2009.04.041. Epub 2009 May 3.

Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer?

PMID: 19427109
DOI: 10.1016/j.eururo.2009.04.041

Comparative Study

Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer?

Guido Dalbagni. Eur Urol. 2009 Aug.

. 2009 Aug;56(2):257-8; discussion 258-9.

doi: 10.1016/j.eururo.2009.04.041. Epub 2009 May 3.

Author

PMID: 19427109
DOI: 10.1016/j.eururo.2009.04.041

No abstract available

PubMed Disclaimer

Comment on

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.
Malmström PU, Sylvester RJ, Crawford DE, Friedrich M, Krege S, Rintala E, Solsona E, Di Stasi SM, Witjes JA. Malmström PU, et al. Eur Urol. 2009 Aug;56(2):247-56. doi: 10.1016/j.eururo.2009.04.038. Epub 2009 Apr 24. Eur Urol. 2009. PMID: 19409692

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information